We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here
Refer and earnSupport
logosearch
Create Account
hamburger
home
breadcrumbStocks
breadcrumbMono Pharmacare Limited Share Price

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

₹0.00
₹0.00
arrow

LOWER/UPPER CIRCUITS

₹23.10
₹25.50
arrow
Mono Pharmacare Limited Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 38.3%, in the last year to ₹169.32 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 25.68% in the last year to ₹3.09 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
notePrice to Earning Ratio,is 13.89, lower than its sector PE ratio of 43.9.
View more

Similar stocks

Mono Pharmacare Limited is engaged in the business of marketing of pharmaceutical products and also, it is distributors of various pharmaceutical companies. It works with various contract manufacturers who manufacture pharmaceutical products on its behalf based on compositions given by it and subsequently it sells those products under its brand ‘DLS Export’. It is also distributors to various pharmaceutical companies. As on February 28, 2023, it is dealing with (distributors and stockists) many pharmaceutical companies and also, it is connected with many customers/vendors who are a mix of retail pharmacy stores as well as wholesalers. It promoters have a combined experience of more than a decade in the pharmaceutical industry. Its Promoters have been the pillars of its Company’s growth since beginning and with their enriching experience and progressive thinking, it aims to continue to grow in the pharmaceutical industry.
personal

Grow your wealth with more research recommendations

+91